Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
215 studies found for:    panitumumab
Show Display Options
Rank Status Study
1 Completed
Has Results
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: panitumumab
2 Completed
Has Results
Panitumumab in Children With Solid Tumors
Condition: Solid Tumors
Intervention: Biological: Panitumumab
3 Completed Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Panitumumab
4 Recruiting Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: Panitumumab;   Drug: Cabozantinib
5 Active, not recruiting A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: panitumumab, TAS-102
6 Unknown  Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)
Condition: Carcinoma, Squamous Cell
Intervention: Drug: infusions of Panitumumab
7 Active, not recruiting
Has Results
PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)
Conditions: Cancer;   Carcinoma;   Head and Neck Cancer;   Metastases;   Metastatic Cancer;   Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck;   Oncology;   Squamous Cell Carcinoma;   Tumors
Intervention: Drug: Panitumumab
8 Completed
Has Results
Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
Conditions: Colorectal Cancer;   Metastatic Cancer
Intervention: Biological: Panitumumab
9 Recruiting Phase I Panitumumab IRDye800 Optical Imaging Study
Condition: Head and Neck Cancer
Intervention: Drug: Panitumumab IRDye 800
10 Completed Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Biological: Panitumumab
11 Completed
Has Results
Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer
Conditions: Biliary Tract Cancer;   Gallbladder Cancer
Interventions: Drug: Panitumumab;   Drug: oxaliplatin;   Drug: gemcitabine
12 Completed
Has Results
Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance "Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene" (All-patient Surveillance)
Condition: Advanced or Recurrent Colorectal Cancer
Intervention: Drug: Panitumumab
13 Terminated Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: Panitumumab and bortezomib
14 Withdrawn Study of Panitumumab in the Treatment of Carcinoid Syndrome
Condition: Carcinoid Syndrome
Intervention: Drug: Panitumumab
15 Recruiting Panitumumab and RAS, DIagnostically-useful Gene Mutation for mCRC).
Condition: Colorectal Cancer
Interventions: Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab;   Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, bevacizumab
16 Withdrawn Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies
Conditions: Adenoma, Pleomorphic;   Mixed Salivary Gland Tumor;   Salivary Gland Tumor, Mixed;   Syringoma, Chondroid
Interventions: Radiation: Radiation;   Drug: Panitumumab
17 Terminated Preoperative Panitumumab and Radiotherapy in Rectal Cancer
Condition: Rectal Cancer
Intervention: Drug: panitumumab
18 Recruiting Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer
Condition: Cancer
Intervention: Drug: Panitumumab
19 Recruiting Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: panitumumab;   Drug: Randomization to No Panitumumab
20 Completed
Has Results
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Panitumumab;   Drug: Irinotecan

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.